U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07578857) titled 'Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia' on May 05.
Brief Summary: Withania somnifera and Syzygium cumini are known for their potential therapeutic effects, particularly in managing lipid disorders. This study was aimed to provide valuable insights into their separate and synergistic effect of Withania somnifera (Ashwagandha) and Syzygium cumini (Jamun) on hyperlipidemic patients. The study included 60 patients, equally divided into four groups. Pre- and post-treatment assessments were conducted over 3 months. Each group recieved different treatment. Data was analyzed using SPSS version 21 through pa...